Scope
Reference
1587
Description
This market exercise was for the provision of a solution to advise the detection of IV infiltrations and extravasations early that includes the following:
• Monitoring equipment and Consumables
NHS Supply Chain have a mandate from the Department of Health and Social Care (DHSC) to drive the availability of innovative products to the NHS. NHS Supply Chain believe the product sourced by this contract (which is not covered by any of its current Framework Agreements) falls within this remit as a "disruptive" innovative product and has been identified to provide enhanced patient benefits specifically;
Patient - improving patient safety Prevention of Never Event - which can lead to skin necrosis, Amputation, Nerve Damage for our most vulnerable patients, Neonates, paediatrics, sedated patients, critically ill and patients with cognitive deficits, along with Patients receiving Vesicant medications.
NHS Supply Chain intends to enter into a Framework Agreement (FAG) with an identified supplier of these products/services (alongside the existing framework Infusion Pumps Administration) following a 10 calendar day publication of a Transparency notice should there only be only 1 available supplier using procedure Direct Award as defined in the Procurement Act 2023.
The Term of this Framework Agreement is anticipated to be 12 months, with the option to extend to a maximum term of 48 months. As part of its strategy, NHS Supply Chain anticipates engaging with suppliers of these products/services with a view to ultimately include this solution within the scope of the Framework for Infusion Pumps Administration Sets and Associated products which is due to renewal on 30th September 2026
The Framework Agreement will be between NHS Supply Chain and the Supplier, however 1) NHSSC, 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework.
Electronic ordering will be used, and electronic invoicing will be accepted, and electronic payment will be used.
For the avoidance of doubt and notwithstanding the estimate indicated, NHSSC does not guarantee any level of purchase through the framework and advises applicants that the framework shall be established on a non-exclusive basis.
Commercial tool
Establishes a framework
Framework
Maximum percentage fee charged to suppliers
0%
Further information about fees
0
Justification for framework term over 4 years
n/a
Contracting authorities that may use the framework
The Framework will be between the Authority and individual Supplier(s). The Authority will be entitled to purchase Goods and/or Services which we will make available for purchase by:
-any NHS Trust;
-any other NHS entity;
-any government department, agency or other statutory body (for the avoidance of doubt including local authorities) and/or
-any private sector entity active in the UK healthcare sector.
Contracting authority location restrictions
- UK - United Kingdom
Contract 1. Peripheral IV Site Monitoring
Supplier
Contract value
- £2,000,000 excluding VAT
- £2,400,000 including VAT
Above the relevant threshold
Earliest date the contract will be signed
4 September 2025
Contract dates (estimated)
- 15 September 2025 to 30 September 2026
- Possible extension to 14 September 2029
- 4 years
Description of possible extension:
Allowable extension for a Framework Period to extend for a total of 4 years
Main procurement category
Goods
CPV classifications
- 30232000 - Peripheral equipment
Participation
Particular suitability
- Small and medium-sized enterprises (SME)
- Voluntary, community and social enterprises (VCSE)
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - technical reasons
Traditional methods rely on periodic clinician assessments, which can miss early signs of infiltration or extravasation, leading to serious complications such as skin necrosis, nerve damage, or medication dosing errors. The ivWatch Patient Monitoring System provides continuous, non-invasive monitoring using optical sensor technology and proprietary algorithms to detect infiltrations at their earliest stages, often before visible signs are present. iv.Watch technology has demonstrated exceptional clinical value in preventing infiltration and extravasation injuries associated with peripheral intravenous (PIV) therapy. This innovation enhances patient safety, reduces liability, and complements clinician assessments, addressing the limitations of periodic monitoring.
Research has been carried out on the benefits of the iv Watch technology and can be found in the British Journal of Nursing: British Journal of Nursing - Addressing and mitigating the high costs of extravasation and infiltration to patients and healthcare organisations
Due to the absence of competition for technical reasons and that the Manufacturer is only just entering the UK market, only this supplier/distributor can supply the goods required.
Procurement Act 2023, Section 41, Schedule 5, Section 5 (b)
"There are no reasonable alternatives to those goods, services or works"
Supplier
HEALTHCARE 21 (UK) LIMITED
- Public Procurement Organisation Number: PBGH-8572-LNQT
- Companies House: 05020682
Unit B1-B2 Bond Close
Basingstoke
RG24 8PZ
United Kingdom
Email: tenders@hc21.group
Region: UKJ37 - North Hampshire
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): No
Contract 1. Peripheral IV Site Monitoring
Contracting authority
SUPPLY CHAIN COORDINATION LIMITED
- Public Procurement Organisation Number: PLLH-1887-BMRL
Wellington House, 133-155 Waterloo Road
London
SE1 8UG
United Kingdom
Contact name: Jennifer Davidson
Email: Jennifer.Davidson@supplychain.nhs.uk
Website: https://www.supplychain.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - sub-central government